These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 36551230)

  • 1. New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer's Disease.
    Hao Y; Xie B; Fu X; Xu R; Yang Y
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Non-coding RNAs in Alzheimer's Disease: Pathogenesis, Novel Biomarkers, and Potential Therapeutic Targets.
    Saleh O; Albakri K; Altiti A; Abutair I; Shalan S; Mohd OB; Negida A; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2024; 23(6):731-745. PubMed ID: 37211844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances with Long Non-Coding RNAs in Alzheimer's Disease as Peripheral Biomarker.
    Garofalo M; Pandini C; Sproviero D; Pansarasa O; Cereda C; Gagliardi S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis.
    Shobeiri P; Alilou S; Jaberinezhad M; Zare F; Karimi N; Maleki S; Teixeira AL; Perry G; Rezaei N
    PLoS One; 2023; 18(3):e0281784. PubMed ID: 36947499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease.
    Cortini F; Roma F; Villa C
    Ageing Res Rev; 2019 Mar; 50():19-26. PubMed ID: 30610928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of long non-coding RNAs in the pathophysiology of Alzheimer's disease and other dementias.
    Teixeira LCR; Mamede I; Luizon MR; Gomes KB
    Mol Biol Rep; 2024 Feb; 51(1):270. PubMed ID: 38302810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression Network Analysis Revealing the Potential Regulatory Roles of lncRNAs in Alzheimer's Disease.
    Wu J; Chen L; Zheng C; Xu S; Gao Y; Wang J
    Interdiscip Sci; 2019 Dec; 11(4):645-654. PubMed ID: 30715720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer's disease.
    Ahmadi S; Zobeiri M; Bradburn S
    Metab Brain Dis; 2020 Jun; 35(5):681-693. PubMed ID: 32185592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research progress on lncRNAs in Alzheimer's disease.
    Xiong WD; Xu KY; Lu L; Li JL
    Yi Chuan; 2022 Mar; 44(3):189-197. PubMed ID: 35307642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of long noncoding RNAs highlights region-specific altered expression patterns and diagnostic roles in Alzheimer's disease.
    Zhou M; Zhao H; Wang X; Sun J; Su J
    Brief Bioinform; 2019 Mar; 20(2):598-608. PubMed ID: 29672663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
    Lee DY; Moon J; Lee ST; Jung KH; Park DK; Yoo JS; Sunwoo JS; Byun JI; Shin JW; Jeon D; Jung KY; Kim M; Lee SK; Chu K
    J Alzheimers Dis; 2015; 45(3):837-49. PubMed ID: 25624420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of age- and gender-associated long noncoding RNAs in the human brain with Alzheimer's disease.
    Cao M; Li H; Zhao J; Cui J; Hu G
    Neurobiol Aging; 2019 Sep; 81():116-126. PubMed ID: 31280115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment.
    Jin H; Du W; Huang W; Yan J; Tang Q; Chen Y; Zou Z
    Mol Ther Nucleic Acids; 2021 Sep; 25():613-637. PubMed ID: 34589282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNAs in brain development, synaptic biology, and Alzheimer's disease.
    Shi C; Zhang L; Qin C
    Brain Res Bull; 2017 Jun; 132():160-169. PubMed ID: 28347717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease.
    Liu Y; Cheng X; Li H; Hui S; Zhang Z; Xiao Y; Peng W
    Front Immunol; 2022; 13():908076. PubMed ID: 35720333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNAs and Alzheimer's Disease: Towards Personalized Diagnosis.
    Mosquera-Heredia MI; Vidal OM; Morales LC; Silvera-Redondo C; Barceló E; Allegri R; Arcos-Burgos M; Vélez JI; Garavito-Galofre P
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding RNAs in Alzheimer's disease.
    Tan L; Yu JT; Hu N; Tan L
    Mol Neurobiol; 2013 Feb; 47(1):382-93. PubMed ID: 23054683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer's Disease.
    Ou GY; Lin WW; Zhao WJ
    J Alzheimers Dis; 2021; 82(1):169-183. PubMed ID: 34024830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying lncRNA-miRNA-mRNA networks to investigate Alzheimer's disease pathogenesis and therapy strategy.
    Ma N; Tie C; Yu B; Zhang W; Wan J
    Aging (Albany NY); 2020 Feb; 12(3):2897-2920. PubMed ID: 32035423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Layers of
    Spreafico M; Grillo B; Rusconi F; Battaglioli E; Venturin M
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29997370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.